Standard Operating Procedure Audit Programmes Internal ...
• The International Standards for the Professional Practice of Internal Auditing of the Institute of Internal Auditors. • The Code of Ethics. • EMA Risk Register. • The Internal Audit Charter of the European Medicines Agency, as adopted by the Management Board. • European Medicines Agency Internal Audit Manual.
Download Standard Operating Procedure Audit Programmes Internal ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
Prevent : Training catalogue - GOV.UK
assets.publishing.service.gov.uknot to preach the message of Islam, but to show the essence of Islam and the practice of the Muslim faith. To help build trust and confidence within communities and partnerships Target Audience Frontline staff, including police, social services, probation, education, health staff and local communities. Description
Clinical Practice Procedures: Other/Clinical handover
www.ambulance.qld.gov.auThe Digital Clinical Practice Manual is expressly intended for use by appropriately qualified QAS clinicians when performing duties and delivering ambulance services for, and on behalf of, the QAS. The QAS disclaims, to the maximum extent permitted by law, all responsibility and all liability (including without limitation,
Internal Revenue Service Department of the Treasury
www.irs.govInternal Revenue Code. In seeking such a waiver, the employer must submit a written statement to the Internal Revenue Service, signed under penalties of perjury, setting forth the facts and law on which the employer relies. Although your question concerns the employer’s tax treatment, we wish to point out